Rapport Therapeutics (RAPP) Shares Outstanding (Entity) (2023 - 2026)
Rapport Therapeutics' Shares Outstanding (Entity) came in at 47.96 million for Q2 2026, up 31.4% from 36.5 million a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends
For FY2025, Rapport Therapeutics' Shares Outstanding (Entity) was 38.93 million, up 87.7% from FY2024.
- Going back by year, Shares Outstanding (Entity) was 20.74 million in FY2024 and 1.51 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2023.
- Year-over-year, Shares Outstanding (Entity) has increased for five consecutive quarters, with growth averaging 79.2% over the last five quarters.
- Business Quant data shows RAPP's Shares Outstanding (Entity) at 47.81 million (Q1 2026), 38.93 million (Q4 2025) and 37.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Rapport Therapeutics | 1.61 Bn | 1.61 Bn | - | 47.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.96 Mn |
| Mar 31, 2026 | 47.81 Mn |
| Dec 31, 2025 | 38.93 Mn |
| Sep 30, 2025 | 37.93 Mn |
| Jun 30, 2025 | 36.50 Mn |
| Mar 31, 2025 | 36.50 Mn |
| Dec 31, 2024 | 20.74 Mn |
| Sep 30, 2024 | 36.58 Mn |
| Jun 30, 2024 | 10.67 Mn |
| Mar 31, 2024 | 2.05 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 1.44 Mn |
API Access
Rapport Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=RAPP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "RAPP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=RAPP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();